D-0571-2026 Class II Ongoing

Recalled by Guardian Drug Co. Inc. — Dayton, NJ

FDA drug recall D-0571-2026 was initiated by Guardian Drug Co. Inc. on May 28, 2026 and is designated Class II. Reason for recall: Presence of foreign substance: small metallic particles in chewable tablets. The recall status is ongoing.

Recall details

Product Type
Drugs
Report Date
Jun 10, 2026
Initiation Date
May 28, 2026
Voluntary/Mandated
Voluntary: Firm initiated

Product description

HyVee, Extra Strength Antacid, Calcium Carbonate 750 mg, 96 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82497 1.

Reason for recall

Presence of foreign substance: small metallic particles in chewable tablets.

Distribution pattern

U.S.A. Nationwide

Code information

Lot #: 1276119, expires: Jan 2029.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0571-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0571-2026. Report a data issue: hello@regdatalab.com.